On a more constructive note, I think non-germline targeted gene editing is OK-ish if 1) the goal is to cure or alleviate some really serious diseases, 2) the me

On a more constructive note, I think non-germline targeted gene editing is OK-ish if 1) the goal is to cure or alleviate some really serious diseases, 2) the mechanism of the disease and the prospective treatment are widely believed to be well understood. Stepping out to do experimental genome changes based on outputs from some black-box "AI" is a recipe for a disaster if you ask me. Especially so if the goal is to find "enhancements" for perfectly normal human beings.